Australia markets closed

Applied DNA Sciences, Inc. (APDN)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
3.4500-0.2900 (-7.75%)
At close: 04:00PM EDT
3.4500 0.00 (0.00%)
After hours: 04:19PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 3.23M
Enterprise value 986.14k
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.28
Price/book (mrq)0.76
Enterprise value/revenue 0.11
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.25
52-week change 3-82.52%
S&P500 52-week change 326.43%
52-week high 337.2000
52-week low 33.1100
50-day moving average 37.6520
200-day moving average 316.4360

Share statistics

Avg vol (3-month) 327.63k
Avg vol (10-day) 3116.33k
Shares outstanding 5863.07k
Implied shares outstanding 6863.07k
Float 8682.66k
% held by insiders 112.12%
% held by institutions 125.61%
Shares short (15 Apr 2024) 414.93k
Short ratio (15 Apr 2024) 41.84
Short % of float (15 Apr 2024) 42.19%
Short % of shares outstanding (15 Apr 2024) 41.76%
Shares short (prior month 15 Mar 2024) 413.06k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 301 Nov 2019
Ex-dividend date 4N/A
Last split factor 21:20
Last split date 325 Apr 2024

Financial highlights

Fiscal year

Fiscal year ends 30 Sept 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -80.13%
Operating margin (ttm)-425.18%

Management effectiveness

Return on assets (ttm)-55.96%
Return on equity (ttm)-110.02%

Income statement

Revenue (ttm)9M
Revenue per share (ttm)13.56
Quarterly revenue growth (yoy)-83.10%
Gross profit (ttm)N/A
EBITDA -12.2M
Net income avi to common (ttm)-7.29M
Diluted EPS (ttm)-11.0000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)3.36M
Total cash per share (mrq)3.96
Total debt (mrq)1.12M
Total debt/equity (mrq)27.06%
Current ratio (mrq)1.77
Book value per share (mrq)6.17

Cash flow statement

Operating cash flow (ttm)-7.59M
Levered free cash flow (ttm)-4.02M